NCT01048281 Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
| NCT ID | NCT01048281 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Stomach Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2002-08 |
| Primary Completion | 2099-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2002-08 with a primary completion date of 2099-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn the role genes and proteins play in the development of gastric and esophageal cancer.
Eligibility Criteria
Inclusion Criteria: 1. Over 18 2. Diagnosed with gastric or esophageal cancer OR at an increased hereditary risk for upper GI cancer Exclusion Criteria: 1. Under 18 2. No family or personal history of gastric or esophageal cancer
Contact & Investigator
James M Ford
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT01048281 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stomach Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01048281 currently recruiting?
Yes, NCT01048281 is actively recruiting participants. Contact the research team at bluett@stanford.edu for enrollment information.
Where is the NCT01048281 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT01048281 clinical trial?
NCT01048281 is sponsored by Stanford University. The principal investigator is James M Ford at Stanford University. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.